Neumora Therapeutics, Inc. (NMRA)
$0.48+2.13%Close
SELLCRISIS · day 32
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $89M
- Beta
- 2.97
- P/E (TTM)
- -0.38
- Short % float
- 11.21%
- Days to cover
- 9.0
- SI change
- -13.1%
- 1W
- -12.73%
- 1M
- -60.00%
- vs SPY 1W
- -14.28%
- vs SPY 1M
- -61.76%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 14
- VALUE
- 28
- GROWTH
- 47
- GARP
- 6
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-145.4%
REV YoY-
ROE-242.3%
EPS YoY-
ROA-169.9%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.38
P/E FWD-
SECTOR PE20.12
INDUSTRY PE13.79
P/B1.96
P/FCF-
EV/EBITDA0.14
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.76
ALTMAN Z-
CURR RATIO4.50
ND/EBITDA-
BETA2.97